Double Dose - Stephane Heymans

Stephane Heymans became a staff member of Cardiology in 2003 at the Maastricht University Medical Centre (MUMC), in 2009 appointed professor of Cardiomyopathies (NL) and Inflammation and Matrix Biology (BE) within the Netherlands Heart Institute, the Maastricht University Medical Centre, and the University of Leuven.

His heart failure research focuses on heart with preserved ejection fraction (HFPEF) and dilated cardiomyopathies (DCM) (, Linked in., Pubmed). He is the coordinator of the EarlyHFPEF programme since 2018, and involved as PI in the She-PREDICTS, DOUBLE DOSIS and ARENA PRIME projects. Stephane Heymans is acknowledged for developing a clinical care program and related cohorts of non-ischemic CMP, myocarditis and HFPEF patients at the MUMC (> 1400 patients cohort and biobank of HFPEF and DCM patients with > 12 yrs FU). His translational research program brings together immunologists, microbiologists, geneticists and molecular cardiologists to study the role of genetics, metabolism, inflammation and fibrosis and metabolism in DCM and HFPEF.